Sentences with phrase «symptom severity scale»

Severity of illness (global symptom severity scale), change in symptoms (clinical global improvement scale), and social functioning (Sheehan Disability Scale).

Not exact matches

In addition, the scientists assessed the severity of participants» OCD symptoms before and after the treatment, using a scaled system in which a lower score indicates less severe or less frequent symptoms.

The severity of MS - associated symptoms was assessed using a standardized questionnaire and the Fatigue Severity Scalseverity of MS - associated symptoms was assessed using a standardized questionnaire and the Fatigue Severity ScalSeverity Scale (FSS).

The ONTRAC trial assessed ADHD symptom severity using a parent rating scale, and measured cognitive performance on tests of attention, response inhibition and working memory.

While second - stage results showed no significant differences between participants continuing to receive weekly doses of the active drug, those receiving biweekly doses and those shifted to placebo, Kimball notes that, since it is typical for the severity of HS symptoms to increase and decrease and because the study protocol required treatment discontinuation for participants whose symptoms stopped responding to the drug, larger scale studies will be required to better define the ideal length and frequency of treatment.

An overall «distress» score is also calculated for each symptom on a scale from 0 — 16, by multiplying the frequency by severity scores [2, 27, 28].

If present, symptoms were characterized by the patient as to severity by use of an 8 - cm - long visual analogue scale, previously used elsewhere in a published treatment trial of patients with Lyme disease [20].

Very little is known about the large - scale brain networks that may underlie the cognitive and behavioral symptoms of FXS.To identify large - scale, resting - state networks in FXS that differ from control individuals matched on age, IQ, and severity of behavioral and cognitive symptoms.Cross - sectional, in vivo neuroimaging study conducted in an academic medical center.

At the beginning of the study, the average severity of the men's symptoms measured about 14.5 on a 35 - point scale commonly used by urologists; by the end, the average severity had declined by three points in the placebo group and just two points in the saw palmetto group.

At the beginning of the study, the participants rated the severity of their fibromyalgia symptoms — including pain, fatigue, stiffness, poor sleep, and anxiety — on a scale from 0 to 100 using a standard questionnaire.

The Fatigue Scale was developed as a measure of the severity of specific fatigue - related symptoms, while the Fatigue Severity Scale was designed to assess functional outcomes related to severity of specific fatigue - related symptoms, while the Fatigue Severity Scale was designed to assess functional outcomes related to Severity Scale was designed to assess functional outcomes related to fatigue.

Women were assessed at intake, 12 weeks, and at 3 - and 6 - month follow - up using the Clinician - Administered Posttraumatic Stress Disorder Scale - I (CAPS - I), Structured Clinical Interview for DSM - IV Patient Version (SCID), Addiction Severity Index (ASI), Time Line Follow Back (TLFB), Brief Symptom Inventory (BSI), Treatment Services Review (TSR), Client Satisfaction Questionnaire (CSQ), End - of - Treatment Questionnaire, Evaluation of Treatment Interview, and the Seeking Safety Adherence Scale.

Associations of these scales with the eight definitional symptoms of CFS and with eight domains of functional disability were examined separately in: (1) an overall sample of individuals with a wide range of fatigue severity and symptomatology; (2) a subsample of individuals with CFS - like symptomatology, and, (3) a subsample of healthy controls.

Unlike the Y - BOCS, it was not designed to measure the severity of OCD, but rather, it comprises an inventory of 55 OCD symptoms that are each rated on a 5 - Likert scale.

The Longitudinal Interval Follow - up Evaluation rates severity of psychopathologic symptoms over time using 6 - point Psychiatric Status Rating (PSR) scales for each disorder based on DSM - III - R criteria; these are scored on a week - by - week basis during the interview period (6 or 12 months).

Analysis of covariance showed that compared with the TAU group, the IPT - A group showed significantly fewer clinician - reported depression symptoms on the Hamilton Depression Rating Scale (P =.04), significantly better functioning on the Children's Global Assessment Scale (P =.04), significantly better overall social functioning on the Social Adjustment Scale — Self - Report (P =.01), significantly greater clinical improvement (P =.03), and significantly greater decrease in clinical severity (P =.03) on the Clinical Global Impressions sScale (P =.04), significantly better functioning on the Children's Global Assessment Scale (P =.04), significantly better overall social functioning on the Social Adjustment Scale — Self - Report (P =.01), significantly greater clinical improvement (P =.03), and significantly greater decrease in clinical severity (P =.03) on the Clinical Global Impressions sScale (P =.04), significantly better overall social functioning on the Social Adjustment Scale — Self - Report (P =.01), significantly greater clinical improvement (P =.03), and significantly greater decrease in clinical severity (P =.03) on the Clinical Global Impressions sScale — Self - Report (P =.01), significantly greater clinical improvement (P =.03), and significantly greater decrease in clinical severity (P =.03) on the Clinical Global Impressions scalescale.

Third, instruments used to evaluate PIU applied varying response mechanisms: some used Likert scales, which allow for reporting the degree and severity of symptoms or consequences, and others used binary yes / no responses, which may not fully capture the frequency or severity of a problematic behavior.

Secondary outcomes: thoughts, feelings and behaviour (Borderline Evaluation of Severity Over Time scale (BESOT)-RRB-; positive and negative disposition (Positive and Negative Affect Schedule (PANAS)-RRB-; Beck Depression Inventory (BDI); Symptom Checklist -90-Revised (SCL90R);...

Included studies used several tools for measuring the severity of depressive symptoms, namely the Hamilton Depression Rating Scale (HAM - D), 21 22 30 34 35 Patient Health Questionnaire - 9 (PHQ - 9), 24 36 Geriatric Depression Scale (GDS), 23 26 28 Hopkins Symptom Checklist - 20 (HSCL - 20), 37 38 Montgomery - Asberg Depression Rating Scale (MADRS), 18 25 27 Beck Depression Inventory - Fast Screen (BDI - FS) 39 and Center of Epidemiologic Studies Depression Scale (CES - D).40 These tools have different score ranges (HAM - D = 0 — 53, PHQ - 9 = 0 — 27, GDS = 0 — 15, HSCL - 20 = 0 — 4, MADRS = 0 — 60, BDI - FS = 0 — 21 and CES - D = 0 — 60), with higher scores in all tools representing increasing severity of depressive symptoms.

The Hamilton Rating Scale for Depression — 17 - Item42 was used to evaluate the severity of depressive symptoms.

Each weekly symptom severity level was assigned as presented in Table2, based on the 6 - point PSR scale for major depression and mania plus the 3 - point PSR scale for rating minor depression / dysthymia, hypomania, DSM - IV atypical depression, DSM - III adjustment disorder with depressed mood, and RDC cyclothymic personality.

Diagnosis of PTSD and symptom severity were established with the Clinician - Administered PTSD Scale (CAPS), 12 a semistructured clinician interview consistent with the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition, Text Revision)(DSM - IV - TR).13 Posttraumatic stress disorder diagnostic status was based on meeting the DSM - IV - TR symptom cluster criteria (to be counted as a symptom, minimum frequency = 1 and intensity = 2) and a total CAPS severity score of 45 or higher.14 Total CAPS symptom severity was the primary outcome.

Main Outcome Measures Clinician - rated PTSD symptom severity was the primary outcome and was assessed with the Clinician - Administered PTSD Scale.

AAI, Adult Attachment Interview; AFFEX, System for Identifying Affect Expression by Holistic Judgement; AIM, Affect Intensity Measure; AMBIANCE, Atypical Maternal Behaviour Instrument for Assessment and Classification; ASCT, Attachment Story Completion Task; BAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory; BEST, Borderline Evaluation of Severity over Time; BPD, borderline personality disorder; BPVS - II, British Picture Vocabulary Scale II; CASQ, Children's Attributional Style Questionnaire; CBCL, Child Behaviour Checklist; CDAS - R, Children's Dysfunctional Attitudes Scale - Revised; CDEQ, Children's Depressive Experiences Questionnaire; CDIB, Child Diagnostic Interview for Borderlines; CGAS, Child Global Assessment Schedule; CRSQ, Children's Response Style Questionnaire; CTQ, Childhood Trauma Questionnaire; CTQ, Childhood Trauma Questionnaire; DASS, Depression, Anxiety, Stress Scales; DERS, Difficulties in Emotion Regulation Scale; DIB - R, Revised Diagnostic Interview for Borderlines; DSM, Diagnostic and Statistical Manual of Mental Disorders; EA, Emotional Availability Scales; ECRS, Experiences in Close Relationships Scale; EMBU, Swedish acronym for Own Memories Concerning Upbringing; EPDS, Edinburgh Postnatal Depression Scale; FES, Family Environment Scale; FSS, Family Satisfaction Scale; FTRI, Family Trauma and Resilience Interview; IBQ - R, Infant Behaviour Questionnaire, Revised; IPPA, Inventory of Parent and Peer Attachment; K - SADS, Kiddie Schedule for Affective Disorders and Schizophrenia for School - Age Children; KSADS - E, Kiddie Schedule for Affective Disorders and Schizophrenia - Episodic Version; MMD, major depressive disorder; PACOTIS, Parental Cognitions and Conduct Toward the Infant Scale; PPQ, Perceived Parenting Quality Questionnaire; PD, personality disorder; PPVT - III, Peabody Picture Vocabulary Test, Third Edition; PSI - SF, Parenting Stress Index Short Form; RSSC, Reassurance - Seeking Scale for Children; SCID - II, Structured Clinical Interview for DSM - IV; SCL -90-R, Symptom Checklist 90 Revised; SCQ, Social Communication Questionnaire; SEQ, Children's Self - Esteem Questionnaire; SIDP - IV, Structured Interview for DSM - IV Personality; SPPA, Self - Perception Profile for Adolescents; SSAGA, Semi-Structured Assessment for the Genetics of Alcoholism; TCI, Temperament and Character Inventory; YCS, Youth Chronic Stress Interview; YSR, Youth Self - Report.

Outcomes: Behavioural or psychological symptom frequency (eg, Revised Memory and Behavior Problem Checklist), severity (eg, Behavioral Pathology in Alzheimer's Diseases Rating Scale) or both (eg, Neuropsychiatry Inventory).

Change in the severity of PTSD symptoms, assessed by participants (PDS) and clinicians (clinician administered PTSD scale (CAPS)-RRB-.

A PANSS symptom severity score of > 3 on an item indicated a negative symptom being present (scale 1 — 7, where 1 = symptom absent and 7 = symptom extremely severe).

Severity of ADHD symptoms (Conners Abbreviated Symptom Questionnaire for teachers [ASQ - Teacher]-RRB-, tic severity (Yale Global Tic Severity Scale [YGTSS]-RRB-, and global functioning (Children's Global Assessment Scale [C - GASeverity of ADHD symptoms (Conners Abbreviated Symptom Questionnaire for teachers [ASQ - Teacher]-RRB-, tic severity (Yale Global Tic Severity Scale [YGTSS]-RRB-, and global functioning (Children's Global Assessment Scale [C - GAseverity (Yale Global Tic Severity Scale [YGTSS]-RRB-, and global functioning (Children's Global Assessment Scale [C - GASeverity Scale [YGTSS]-RRB-, and global functioning (Children's Global Assessment Scale [C - GAS]-RRB-.

Three variables showed a significant contribution: allocation to cognitive behaviour therapy (B 2.064; SE 0.726; P = 3D0.0045; Exp (B) 7.878); duration of illness (B — 0.144; SE 0.054; P = 3D0.0079; Exp (B) 0.866); severity of symptoms on the psychiatric assessment scale (B — 1.893; SE 0.815; P = 3D0.02; Exp (B) 0.151).

To be accepted into the trial, patients had to meet the following criteria: 18 to 65 years old; meeting diagnostic criteria for PTSD as determined by the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM - IV), 13 with PTSD being the main problem; scoring 20 or higher on the Posttraumatic Diagnostic Scale (PDS), 14 indicating moderate to severe symptom severity; and intervention starting within 6 months after the accident.

Symptom severity was assessed at baseline and annually using the Positive and Negative Symptom Scale score.

Negative symptoms and clinical severity were assessed using five items from the schizophrenia Postive and Negative Syndrome Scale (PANSS) negative symptoms subscale (blunted affect, emotional withdrawal, poor rapport, social withdrawal and verbal fluency).

Prognostic factors Severity of positive and negative symptoms (schedules for positive and negative symptoms); course of illness over the past 2 years; level of functioning (Global Assessment of Functioning scale (GAF)-RRB-; premorbid functioning (Premorbid Adjustment scale); duration of untreated psychosis (interview for retrospective assessment of onset of schizophrenia); days of hospitalisation; number of contacts with psychiatric services; number of days in supported housing.

The co-occurrence of invisible symptoms (fatigue, depression and apathy) was stated using validated, self - administered tools: Fatigue Severity Scale (FSS); Beck Depression Inventory - Second Edition (BDI - II); Apathy Evaluation... Scale (AES).

Measures utilized include Life Stressors Checklist (LSC - R), the Global Severity Index (GSI), the Social Role Functioning Index, the Addiction Severity Index (ASI), the Current Exposure to Interpersonal Abuse (CEIA) Scale, the Current Exposure to Other Stressors (CEOS) Scale, the PTSD Symptom Scale (PSS), the Brief Symptom Inventory (BSI), a six item safety scale, a three - item feeling Response — Dissociation Scale, and a nine item - Feeling Response - Trauma Coping IScale, the Current Exposure to Other Stressors (CEOS) Scale, the PTSD Symptom Scale (PSS), the Brief Symptom Inventory (BSI), a six item safety scale, a three - item feeling Response — Dissociation Scale, and a nine item - Feeling Response - Trauma Coping IScale, the PTSD Symptom Scale (PSS), the Brief Symptom Inventory (BSI), a six item safety scale, a three - item feeling Response — Dissociation Scale, and a nine item - Feeling Response - Trauma Coping IScale (PSS), the Brief Symptom Inventory (BSI), a six item safety scale, a three - item feeling Response — Dissociation Scale, and a nine item - Feeling Response - Trauma Coping Iscale, a three - item feeling Response — Dissociation Scale, and a nine item - Feeling Response - Trauma Coping IScale, and a nine item - Feeling Response - Trauma Coping Index.

Measures utilized include the Life Stressor Checklist — Revised [LSC - R], Global Severity Index (GSI) from the Brief Symptom Inventory, the Addiction Severity Index (ASI), and the Posttraumatic Symptom Scale.

Change in severity of posttraumatic stress disorder symptoms as measured by the National Stressful Events PTSD Scale

Measures utilized include the Beck Depression Inventory (BDI), the Spielberger State - Trait Anxiety Inventory (STAI), the Subjective Units of Disturbance (SUD), the Dissociative Experiences Scale (DES), Impact of Events Scale (IES), the Modified PTSD (MPTSD) Scale, the Global Severity Index (GSI), Positive Symptom Distress subscale (PSD), and the Dissociative Interview Schedule (DIS).

Hospital Anxiety and Depression scale (HAD).31 Fourteen depression and anxiety items are rated on by three individual options per item relating to severity of the symptom.

Compared with the TAU group, the IPT - A group showed significantly fewer clinician - reported depression symptoms on the HAMD and BDI, significantly better functioning on the C - GAS, significantly better overall social functioning on the SAS - SR, and significantly greater clinical improvement and significantly greater decrease in clinical severity on the CGI scale.

Suicidality was assessed with 3 items (hopelessness, thoughts of death, and thoughts of suicide) from the SCL - 20.27 Physical symptom severity was assessed with the PHQ - 15, a 15 - item scale scored from 0 to 30.28 Health - related quality of life was assessed on the Short Form - 12 (SF - 12) subscales measuring physical health and mental health — related functioning.29 Subscales are normed for the general population so that mean and standard deviation are approximately 50 and 10, respectively.30 Pain intensity and interference were assessed with the Adapted Numeric Rating Scale for Pain31; each item is rated on a 0 - to - 10 Likert sscale scored from 0 to 30.28 Health - related quality of life was assessed on the Short Form - 12 (SF - 12) subscales measuring physical health and mental health — related functioning.29 Subscales are normed for the general population so that mean and standard deviation are approximately 50 and 10, respectively.30 Pain intensity and interference were assessed with the Adapted Numeric Rating Scale for Pain31; each item is rated on a 0 - to - 10 Likert sScale for Pain31; each item is rated on a 0 - to - 10 Likert scalescale.

Primary outcomes were the Posttraumatic Diagnostic Scale (PDS) 25,26 for PTSD symptoms and the Symptom Checklist Depression Scale (SCL - 20) for depressive symptoms.27 The PDS (17 items) assesses severity of PTSD symptoms over the prior 4 weeks with high internal consistency and test - retest reliability26; scores are summed and range from 0 to 51; scores of 10 or less are mild; 11 to 20, moderate; 21 to 35, moderate to severe; and at least 36, severe.

Participants classified as having dementia satisfied DSM - IV (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) criteria, had dementia severity ≥ 1.0 on the Clinical Dementia Rating Scale and exhibited symptoms of dementia for at least 6 months.

Depression Anxiety Stress Scale (DASS) has three subscales, each with seven items rating the severity / frequency of symptoms of stress, anxiety and depression, respectively.

Response (score of 1 or 2 (much or very much improved) on the Clinical Global Impressions - Improvement scale); symptom severity or investigator defined response on closely related measures; symptom severity (clinician rated DSM based anxiety scales such as the Child Yale - Brown Obsessive - Compulsive Scale); adverse evscale); symptom severity or investigator defined response on closely related measures; symptom severity (clinician rated DSM based anxiety scales such as the Child Yale - Brown Obsessive - Compulsive Scale); adverse evScale); adverse events.

Clinician - based autism severity ratings (based on the Autism Diagnostic Observation Schedule) did not significantly predict parenting stress; however, parental report of the severity of ASD - associated symptoms (from the Social Responsiveness Scale) showed a significant relation to stress.

Obsessive — compulsive severity was measured using the Children's Yale - Brown Obsessive — Compulsive Scale, and depressive symptoms were rated using the Children's Depression Rating Scale - Revised.

Methods: Four hundred seventy adults in Chieti, Italy, completed an anonymous and confidential survey regarding their childhood exposure to parental alienating behaviors (using the Baker Strategy Questionnaire), quality of the parent — child relationship (using Parental Bonding Instruments), self - esteem (using Rosenberg Self - Esteem Scale), and global psychological distress (using Global Severity Index of Symptom Checklist -90-Revised).

The Dimensional Obsessive - Compulsive Scale (DOCS) is a self - report instrument that assesses the severity of the four most empirically supported OC symptom dimensions (Contamination, Responsibility, Unacceptable Thoughts, and Symmetry).

Presence and severity of child primary anxiety disorder (Anxiety Disorders Interview Schedule for DSM - IV, child / parent versions), improvement in child presentation of anxiety (Clinical Global Impression — Improvement scale), and change in child anxiety symptoms (Spence Children's Anxiety Scale, child / parent version and Child Anxiety Impact scale, parent version) were assessed at post-treatment and for those in the two active treatment groups, 6 months post-treatscale), and change in child anxiety symptoms (Spence Children's Anxiety Scale, child / parent version and Child Anxiety Impact scale, parent version) were assessed at post-treatment and for those in the two active treatment groups, 6 months post-treatScale, child / parent version and Child Anxiety Impact scale, parent version) were assessed at post-treatment and for those in the two active treatment groups, 6 months post-treatscale, parent version) were assessed at post-treatment and for those in the two active treatment groups, 6 months post-treatment.